Psoriasis and risk of type 2 diabetes among women and men in the United States: A population-based cohort study

Journal of Investigative Dermatology

Volumn 132, Issue 2, 2012, Pages 291-298

  Li, Wenqing ^a   Han, Jiali ^a,b   Hu, Frank B ^a,b   Curhan, Gary C ^a,b   Qureshi, Abrar A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSORIASIS; RETROSPECTIVE STUDY; UNITED STATES;

EID: 84855940280     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.319     Document Type: Article

References (48)

1. Brauchli YB, Jick SS, Meier CR (2008) Psoriasis and the risk of incident diabetes mellitus: a population-based study. Br J Dermatol 159:1331-7
2. Brodell RT, Williams L (1999) A corticosteroid-induced flare of psoriasis. How to control or, better yet, avoid. Postgrad Med 106:31-2
3. Cohen AD, Dreiher J, Shapiro Y et al. (2008) Psoriasis and diabetes: a population-based cross-sectional study. J Eur Acad Dermatol Venereol 22:585-9 (Pubitemid 351541054)
4. Davidovici BB, Sattar N, Jorg PC et al. (2010) Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol 130:1785-96
5. Dominguez PL, Assarpour A, Kuo H et al. (2009) Development and pilot-testing of a psoriasis screening tool. Br J Dermatol 161:778-84
6. Driessen RJ, Boezeman JB, Van De Kerkhof PC et al. (2009) Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies. J Dermatolog Treat 20:42-7
7. Duncan BB, Schmidt MI, Pankow JS et al. (2003) Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 52:1799-805 (Pubitemid 36792473)
8. Field AE, Coakley EH, Must A et al. (2001) Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 161:1581-6 (Pubitemid 32681139)
9. Garcia C, Feve B, Ferre P et al. (2010) Diabetes and inflammation: fundamental aspects and clinical implications. Diabetes Metab 36: 327-38
10. Gelfand JM, Stern RS, Nijsten T et al. (2005) The prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermatol 52:23-6 (Pubitemid 40038931)
11. Gerdes S, Zahl VA, Knopf H et al. (2008) Comedication related to comorbidities: a study in 1203 hospitalized patients with severe psoriasis. Br J Dermatol 159:1116-23
12. Giovannucci E, Harlan DM, Archer MC et al. (2010) Diabetes and cancer: a consensus report. Diabetes Care 33:1674-85
13. Gisondi P, Tessari G, Conti A et al. (2007) Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 157:68-73 (Pubitemid 46934281)
14. Gomez EC, Frost P (1976) Induction of glycosuria and hyperglycemia by topical corticosteroid therapy. Arch Dermatol 112:1559-62
15. Gudjonsson JE, Johnston A, Sigmundsdottir H et al. (2004) Immunopathogenic mechanisms in psoriasis. Clin Exp Immunol 135:1-8 (Pubitemid 38067920)
16. He C, Zhang C, Hunter DJ et al. (2010) Age at menarche and risk of type 2 diabetes: results from 2 large prospective cohort studies. Am J Epidemiol 171:334-44
17. Henseler T, Christophers E (1985) Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 13:450-6 (Pubitemid 15016489)
18. Henseler T, Christophers E (1995) Disease concomitance in psoriasis. J Am Acad Dermatol 32:982-6
19. Hu FB, Meigs JB, Li TY et al. (2004) Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 53:693-700 (Pubitemid 38270639)
20. Kaye JA, Li L, Jick SS (2008) Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis. Br J Dermatol 159:895-902
21. Kimball AB, Robinson Jr D, Wu Y et al. (2008) Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002. Dermatology 217:27-37 (Pubitemid 351896565)
22. Langley RG, Krueger GG, Griffiths CE (2005) Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis 64(Suppl 2): ii18-23 (Pubitemid 40288514)
23. Lindegard B (1986) Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes. Dermatologica 172:298-304 (Pubitemid 16014779)
24. Loffredo S, Ayala F, Marone G et al. (2009) Immunopathogenesis of psoriasis and pharmacological perspectives. J Rheumatol Suppl 83: 9-11
25. Love TJ, Qureshi AA, Karlson EW et al. (2011) Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006. Arch Dermatol 147:419-24
26. Lowes MA, Bowcock AM, Krueger JG (2007) Pathogenesis and therapy of psoriasis. Nature 445:866-73
27. Lowes MA, Kikuchi T, Fuentes-Duculan J et al. (2008) Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 128:1207-11 (Pubitemid 351543220)
28. Manson JE, Rimm EB, Stampfer MJ et al. (1991) Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet 338:774-8
29. Naldi L, Chatenoud L, Belloni A et al. (2008) Medical history, drug exposure and the risk of psoriasis. Evidence from an Italian case-control study. Dermatology 216:125-30 (Pubitemid 351158576)
30. Neimann AL, Shin DB, Wang X et al. (2006) Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 55: 829-35 (Pubitemid 44556851)
31. Pearce DJ, Morrison AE, Higgins KB et al. (2005) The comorbid state of psoriasis patients in a university dermatology practice. J Dermatolog Treat 16:319-23 (Pubitemid 43170202)
32. Pradhan AD, Manson JE, Rifai N et al. (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327-34 (Pubitemid 32656163)
33. Qureshi AA, Choi HK, Setty AR et al. (2009) Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Arch Dermatol 145:379-82
34. Qureshi AA, Dominguez PL, Choi HK et al. (2010) Alcohol intake and risk of incident psoriasis in US women: a prospective study. Arch Dermatol 146:1364-9
35. Saraceno R, Schipani C, Mazzotta A et al. (2008) Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasis. Pharmacol Res 57:290-5
36. Setty AR, Curhan G, Choi HK (2007a) Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II. Arch Intern Med 167:1670-5 (Pubitemid 47280349)
37. Setty AR, Curhan G, Choi HK (2007b) Smoking and the risk of psoriasis in women: Nurses' Health Study II. Am J Med 120:953-9 (Pubitemid 350011082)
38. Shapiro J, Cohen AD, David M et al. (2007) The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. J Am Acad Dermatol 56:629-34 (Pubitemid 46400186)
39. Smith-Warner SA, Spiegelman D, Ritz J et al. (2006) Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. Am J Epidemiol 163: 1053-64 (Pubitemid 43987598)
40. Solomon DH, Love TJ, Canning C et al. (2010) Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis. Ann Rheum Dis 69:2114-7
41. Sommer DM, Jenisch S, Suchan M et al. (2006) Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 298:321-8
42. Stern MP (1995) Diabetes and cardiovascular disease. The "common soil" hypothesis. Diabetes 44:369-74
43. Takahashi H, Tsuji H, Takahashi I et al. (2008) Plasma adiponectin and leptin levels in Japanese patients with psoriasis. Br J Dermatol 159:1207-8
44. Vena GA, Altomare G, Ayala F et al. (2010) Incidence of psoriasis and association with comorbidities in Italy: a 5-year observational study from a national primary care database. Eur J Dermatol 20:593-8
45. Weinstein AR, Sesso HD, Lee IM et al. (2004) Relationship of physical activity vs body mass index with type 2 diabetes in women. JAMA 292:1188-94 (Pubitemid 39167409)
46. Willi C, Bodenmann P, Ghali WA et al. (2007) Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 298:2654-64 (Pubitemid 350254957)
47. Wu Y, Mills D, Bala M (2008) Psoriasis: cardiovascular risk factors and other disease comorbidities. J Drugs Dermatol 7:373-7
48. Zaghloul SS, Goodfield MJ (2004) Objective assessment of compliance with psoriasis treatment. Arch Dermatol 140:408-14 (Pubitemid 38469243)